- October 20, 2026
Confusion with Marine Plaza investors at odds
[ad_1] An investor behind the £100million Marine Plaza development on Southend seafront has vowed he will press ahead with the scheme after concerns about its
Barings corporate investors trustee buys shares worth over $200k By Investing.com
[ad_1] Barings Corporate Investors (NYSE:MCI) reported a recent transaction involving its Trustee, Edward P. Grace III, who purchased shares of the company valued at over
Equities investors renew interest in banks
[ad_1] The Nigerian equities market is witnessing bargain hunting as investors renew interest in banking stocks. Analysts believe the sentiment will be sustained. Gbolahan Ologunro,
Institutional investors control 73% of W.W. Grainger, Inc. (NYSE:GWW) and were rewarded last week after stock increased 4.8%
[ad_1] Key Insights Significantly high institutional ownership implies W.W. Grainger’s stock price is sensitive to their trading actions A total of 15 investors have a
Dundee United owner reveals discussions with potential investors
[ad_1] Dundee United owner reveals discussions with potential investors Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal
Are investors making the same mistakes they made in 2022?
[ad_1] People are looking towards the stock market again, but could be repeating their mistakes. Markets have gone gangbusters over the past few years and
Raspberry Pi shares surge again as retail investors start trading stock
[ad_1] For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free
Japan’s Nikkei Climbs As Investors Eye BoJ Decision
[ad_1] What’s going on here? Japan’s Nikkei share average gained 0.4% to reach 38,872.21 after the Bank of Japan’s decision to maintain its current policy
Aussie high-flyer’s wings clipped by US investors
[ad_1] Red-hot biotech Telix Pharmaceuticals went to the United States equities markets to spread its wings. Instead, they’ve been clipped. After a few weeks of
Telix pulls $300m Nasdaq IPO as investors demand deep discount
[ad_1] Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 million ($300 million) and list on the Nasdaq after being forced to